Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,724 recalls · Class II, newest first

Class II · Moderate risk

Glipizide XL

CGMP Deviations; rejected product was used to manufacture final bulk lot

Terminated cGMP deviation Pfizer Inc. NDC 59762-0541-2 D-0010-2019
Class II · Moderate risk

Thyroid powder

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Alkano Chemicals, Inc NDC 7807-0170-11 D-0008-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-6580-43 D-0024-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-8077-62 D-0023-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-8077-43 D-0022-2019
Class II · Moderate risk

Thyroid Powder

CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation LGM Pharma LLC D-0296-2019
Class II · Moderate risk

Thyroid Powder USP

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Syntec Pharma Corp D-0014-2019
Class II · Moderate risk

Thyroid Powder USP

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Syntec Pharma Corp D-0013-2019
Class II · Moderate risk

Thyroid Powder 25kg/drum

CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Sichuan Friendly Pharmaceutical Co.,Ltd. NDC 7807-0170-11 D-0006-2019
Class II · Moderate risk

ADAA Cataract Drops

Lack of Process Controls

Terminated cGMP deviation Westlab Pharmacy, Inc. dba Westlab Pharmacy NDC 10002-2579-05 D-0090-2019
Class II · Moderate risk

Finafta Baby

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0079-2019
Class II · Moderate risk

Rexall

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0078-2019
Class II · Moderate risk

Rexall

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Terminated cGMP deviation Product Quest Manufacturing LLC D-0077-2019

Recalls by year